Cargando…
Successful treatment of gemcitabine-induced acute interstitial pneumonia with imatinib mesylate: a case report
BACKGROUND: Gemcitabine is currently the standard chemotherapy for the adjuvant treatment of pancreatic cancer. This chemotherapeutic agent is generally well-tolerated, myelosuppression and gastrointestinal toxicity being common side effects. Nevertheless, gemcitabine-induced pulmonary toxicity has...
Autores principales: | Fenocchio, Elisabetta, Depetris, Ilaria, Campanella, Delia, Garetto, Lucia, Schianca, Fabrizio Carnevale, Galizia, Danilo, Grignani, Giovanni, Aglietta, Massimo, Leone, Francesco |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5059971/ https://www.ncbi.nlm.nih.gov/pubmed/27733144 http://dx.doi.org/10.1186/s12885-016-2833-9 |
Ejemplares similares
-
Pursuit of Gene Fusions in Daily Practice: Evidence from Real-World Data in Wild-Type and Microsatellite Instable Patients
por: Berrino, Enrico, et al.
Publicado: (2021) -
Alpha–fetoprotein elevation in NUT midline carcinoma: a case report
por: D’Ambrosio, Lorenzo, et al.
Publicado: (2017) -
Periorbital edema secondary to imatinib mesylate
por: McClelland, Collin M, et al.
Publicado: (2010) -
Cutaneous adverse effects of imatinib mesylate
por: Dogu, Mehmet Hilmi, et al.
Publicado: (2015) -
Complete remission of paraneoplastic vanishing bile duct syndrome after the successful treatment of Hodgkin’s lymphoma: a case report and review of the literature
por: Rota Scalabrini, Delia, et al.
Publicado: (2014)